Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
45,959,265
-
Share change
-
-4,557,239
-
Total reported value
-
$7,520,410,587
-
Put/Call ratio
-
107%
-
Price per share
-
$163.65
-
Number of holders
-
846
-
Value change
-
-$738,435,392
-
Number of buys
-
352
-
Number of sells
-
317
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2021
As of 30 Jun 2021 ISHARES TR - ISHARES BIOTECH (IBB) had 846 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,959,265 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, GOLDMAN SACHS GROUP INC, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, JPMORGAN CHASE & CO, BARCLAYS PLC, and ROYAL BANK OF CANADA.
This table shows 853 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.